Literature DB >> 17414399

Epidemiology of methicillin-resistant Staphylococcus aureus at a pediatric healthcare system, 1991-2003.

Jessica Jungk1, Kathryn Como-Sabetti, Patricia Stinchfield, Patricia Ackerman, Kathleen Harriman.   

Abstract

BACKGROUND: The emergence and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) at a Minneapolis pediatric healthcare facility was investigated.
METHODS: Children with MRSA infections from January 1991 to December 2003 were classified as community-associated (CA) or healthcare-associated (HA) using established criteria. Isolates were subtyped using pulsed-field gel electrophoresis and grouped into pulsed-field types (PFTs). Case and isolate characteristics were compared and temporal trends were assessed.
RESULTS: The first isolate classified as CA-MRSA in this healthcare facility was identified in 1991. CA-MRSA cases (n = 188) were more likely than HA-MRSA cases (n = 83) to have a skin or soft tissue infection (80% versus 59%) and to belong to a racial or ethnic minority group (82% versus 55%), whereas HA-MRSA cases were younger (median age, 3.4 years versus 4.9 years). The proportion of both CA- and HA-MRSA isolates susceptible to clindamycin and erythromycin declined during the study period. Isolates classified as CA-MRSA were more likely than HA-MRSA isolates to be USA300 (21% versus 11%, P = 0.05) and USA400 (62% versus 31%, P < 0.001) PFTs. Associations between case race/ethnicity and isolate PFT were observed independent of case classification.
CONCLUSIONS: CA-MRSA is well established in this pediatric population. Although no discernable changes in CA- or HA-MRSA case characteristics were documented during the study period, significant changes were observed in CA-MRSA isolate characteristics, indicating that this pathogen continues to evolve.

Entities:  

Mesh:

Year:  2007        PMID: 17414399     DOI: 10.1097/01.inf.0000257452.58182.e1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization.

Authors:  G Thomas Ray; Jose A Suaya; Roger Baxter
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

2.  Community-associated methicillin-resistant Staphylococcus aureus in a pediatric emergency department in Newfoundland and Labrador.

Authors:  Erin Peebles; Robert Morris; Roger Chafe
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

3.  Life-threatening infection due to community-acquired methicillin-resistant Staphylococcus aureus: case report and review.

Authors:  Kalomoira Kefala-Agoropoulou; Efthimia Protonotariou; Danai Vitti; Sofia Sarafidou; Athanasia Anastasiou; Konstantinos Kollios; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2009-04-03       Impact factor: 3.183

Review 4.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

5.  Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis.

Authors:  Vanja M Dukic; Diane S Lauderdale; Jocelyn Wilder; Robert S Daum; Michael Z David
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

6.  Treatment Failure Outcomes for Emergency Department Patients with Skin and Soft Tissue Infections.

Authors:  Larissa S May; Mark Zocchi; Catherine Zatorski; Jeanne A Jordan; Richard E Rothman; Chelsea E Ware; Samantha Eells; Loren Miller
Journal:  West J Emerg Med       Date:  2015-10-20

7.  Characteristics and risk factors of hospital acquired - Methicillin-resistant Staphylococcus aureus (HA-MRSA) infection of pediatric patients in a tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Khalid Alrabiah; Sulaiman Al Alola; Esam Al Banyan; Mohammad Al Shaalan; Sameera Al Johani
Journal:  Int J Pediatr Adolesc Med       Date:  2016-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.